Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Basal Cell 3Pancreatic Neoplasms 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Telangiectasis 1Skin Neoplasms 1Rosacea 1Prostatic Neoplasms 1Precancerous Conditions 1Port-Wine Stain 1Pancreatic Intraductal Neoplasms 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nasopharyngeal Neoplasms 1Mixed Tumor, Malignant 1Melanoma 1Lung Neoplasms 1Keratosis, Seborrheic 1Keratosis 1Hemangioma 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma 1Barrett Esophagus 1

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × Tomography, Optical Coherence × Clear all
NCT06679920 2024-12-06

BLOCT

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Recruiting
15 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡